vs

Side-by-side financial comparison of Anterix Inc. (ATEX) and OneMedNet Corp (ONMD). Click either name above to swap in a different company.

Anterix Inc. is the larger business by last-quarter revenue ($1.6M vs $890.0K, roughly 1.8× OneMedNet Corp). OneMedNet Corp runs the higher net margin — -352.8% vs -419.6%, a 66.8% gap on every dollar of revenue. On growth, OneMedNet Corp posted the faster year-over-year revenue change (3323.1% vs 0.4%). OneMedNet Corp produced more free cash flow last quarter ($-1.7M vs $-8.3M). Over the past eight quarters, OneMedNet Corp's revenue compounded faster (66.3% CAGR vs 11.7%).

Anterix Inc. is a U.S.-headquartered wireless communications company that owns licensed 900 MHz spectrum assets, providing secure, dedicated private broadband network solutions for critical infrastructure operators including electric utilities, public safety agencies, and transportation providers. Its primary market is North America, supporting clients requiring highly reliable connectivity for mission-critical operations.

OneMedNet Corp is a U.S.-headquartered healthcare tech firm offering secure cloud-based data sharing and workflow solutions for medical imaging and patient health information. It serves healthcare providers, insurance payers, and life sciences groups, with its core operating market centered in North America.

ATEX vs ONMD — Head-to-Head

Bigger by revenue
ATEX
ATEX
1.8× larger
ATEX
$1.6M
$890.0K
ONMD
Growing faster (revenue YoY)
ONMD
ONMD
+3322.6% gap
ONMD
3323.1%
0.4%
ATEX
Higher net margin
ONMD
ONMD
66.8% more per $
ONMD
-352.8%
-419.6%
ATEX
More free cash flow
ONMD
ONMD
$6.6M more FCF
ONMD
$-1.7M
$-8.3M
ATEX
Faster 2-yr revenue CAGR
ONMD
ONMD
Annualised
ONMD
66.3%
11.7%
ATEX

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
ATEX
ATEX
ONMD
ONMD
Revenue
$1.6M
$890.0K
Net Profit
$-6.6M
$-3.1M
Gross Margin
20.7%
Operating Margin
-576.0%
-353.4%
Net Margin
-419.6%
-352.8%
Revenue YoY
0.4%
3323.1%
Net Profit YoY
-185.6%
-32.3%
EPS (diluted)
$-0.35
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATEX
ATEX
ONMD
ONMD
Q4 25
$1.6M
$890.0K
Q3 25
$1.6M
$177.0K
Q2 25
$1.4M
$155.0K
Q1 25
$1.4M
$137.0K
Q4 24
$1.6M
Q3 24
$1.6M
$142.0K
Q2 24
$1.5M
$227.0K
Q1 24
$1.3M
$248.0K
Net Profit
ATEX
ATEX
ONMD
ONMD
Q4 25
$-6.6M
$-3.1M
Q3 25
$53.5M
$-741.0K
Q2 25
$25.2M
$3.0M
Q1 25
$9.2M
$-1.9M
Q4 24
$7.7M
Q3 24
$-12.8M
$-2.1M
Q2 24
$-15.5M
$-3.6M
Q1 24
$-9.4M
$-2.1M
Gross Margin
ATEX
ATEX
ONMD
ONMD
Q4 25
20.7%
Q3 25
-125.4%
Q2 25
-155.5%
Q1 25
-163.5%
Q4 24
Q3 24
-59.2%
Q2 24
-44.9%
Q1 24
-27.8%
Operating Margin
ATEX
ATEX
ONMD
ONMD
Q4 25
-576.0%
-353.4%
Q3 25
-1262.7%
Q2 25
-1331.0%
Q1 25
-1623.4%
Q4 24
Q3 24
-846.6%
-1645.1%
Q2 24
-984.4%
-1081.1%
Q1 24
-834.2%
-847.2%
Net Margin
ATEX
ATEX
ONMD
ONMD
Q4 25
-419.6%
-352.8%
Q3 25
3449.5%
-418.6%
Q2 25
1775.7%
1923.9%
Q1 25
662.9%
-1388.3%
Q4 24
492.3%
Q3 24
-823.1%
-1449.3%
Q2 24
-1018.0%
-1581.1%
Q1 24
-746.9%
-850.4%
EPS (diluted)
ATEX
ATEX
ONMD
ONMD
Q4 25
$-0.35
$-0.06
Q3 25
$2.86
$-0.01
Q2 25
$1.35
$0.07
Q1 25
$0.51
$-0.06
Q4 24
$0.41
Q3 24
$-0.69
$-0.07
Q2 24
$-0.84
$-0.14
Q1 24
$-0.51
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATEX
ATEX
ONMD
ONMD
Cash + ST InvestmentsLiquidity on hand
$29.5M
$585.0K
Total DebtLower is stronger
$220.0K
Stockholders' EquityBook value
$236.0M
$-3.0M
Total Assets
$417.0M
$2.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATEX
ATEX
ONMD
ONMD
Q4 25
$29.5M
$585.0K
Q3 25
$39.1M
$149.0K
Q2 25
$41.4M
$122.0K
Q1 25
$47.4M
$144.0K
Q4 24
$28.8M
Q3 24
$43.1M
$1.9M
Q2 24
$51.7M
$407.0K
Q1 24
$60.6M
$174.0K
Total Debt
ATEX
ATEX
ONMD
ONMD
Q4 25
$220.0K
Q3 25
Q2 25
Q1 25
$2.3M
Q4 24
Q3 24
$2.3M
Q2 24
$2.4M
Q1 24
Stockholders' Equity
ATEX
ATEX
ONMD
ONMD
Q4 25
$236.0M
$-3.0M
Q3 25
$240.3M
$-3.9M
Q2 25
$184.8M
$-3.8M
Q1 25
$156.6M
$-16.6M
Q4 24
$144.7M
Q3 24
$139.1M
$-14.3M
Q2 24
$148.8M
$-19.2M
Q1 24
$161.0M
$-15.7M
Total Assets
ATEX
ATEX
ONMD
ONMD
Q4 25
$417.0M
$2.2M
Q3 25
$420.4M
$1.5M
Q2 25
$359.6M
$2.3M
Q1 25
$333.1M
$1.7M
Q4 24
$326.7M
Q3 24
$317.2M
$4.4M
Q2 24
$321.1M
$1.0M
Q1 24
$324.9M
$750.0K

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATEX
ATEX
ONMD
ONMD
Operating Cash FlowLast quarter
$-8.3M
$-1.7M
Free Cash FlowOCF − Capex
$-8.3M
$-1.7M
FCF MarginFCF / Revenue
-526.4%
-193.0%
Capex IntensityCapex / Revenue
0.6%
0.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATEX
ATEX
ONMD
ONMD
Q4 25
$-8.3M
$-1.7M
Q3 25
$1.4M
$-1.6M
Q2 25
$-3.1M
$-2.3M
Q1 25
$-16.6M
$-1.9M
Q4 24
$-7.7M
Q3 24
$-2.6M
$-1.9M
Q2 24
$-2.4M
$-1.5M
Q1 24
$6.1M
$-1.5M
Free Cash Flow
ATEX
ATEX
ONMD
ONMD
Q4 25
$-8.3M
$-1.7M
Q3 25
Q2 25
$-2.3M
Q1 25
$-16.6M
$-2.0M
Q4 24
Q3 24
$-2.7M
$-1.9M
Q2 24
$-1.5M
Q1 24
$6.1M
$-1.6M
FCF Margin
ATEX
ATEX
ONMD
ONMD
Q4 25
-526.4%
-193.0%
Q3 25
Q2 25
-1475.5%
Q1 25
-1195.2%
-1425.5%
Q4 24
Q3 24
-173.4%
-1346.5%
Q2 24
-663.9%
Q1 24
484.1%
-626.2%
Capex Intensity
ATEX
ATEX
ONMD
ONMD
Q4 25
0.6%
0.6%
Q3 25
0.0%
Q2 25
1.9%
Q1 25
3.3%
3.6%
Q4 24
0.0%
Q3 24
2.6%
6.3%
Q2 24
0.0%
0.4%
Q1 24
3.2%
2.4%
Cash Conversion
ATEX
ATEX
ONMD
ONMD
Q4 25
Q3 25
0.03×
Q2 25
-0.12×
-0.77×
Q1 25
-1.80×
Q4 24
-1.00×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons